We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.
- Authors
Lee, Jennifer S; Humes, Elizabeth A; Hogan, Brenna C; Buchacz, Kate; Eron, Joseph J; Gill, M John; Sterling, Timothy R; Rebeiro, Peter F; Lima, Viviane Dias; Mayor, Angel; Silverberg, Michael J; Horberg, Michael A; Moore, Richard D; Althoff, Keri N; Design, North American AIDS Cohort Collaboration on Research and
- Abstract
From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.
- Subjects
UNITED States; HIV infections; HIV-positive persons; WORLD Health Organization; TIME; ANTIRETROVIRAL agents; MEDICAL care; PATIENTS; UNITED States. Dept. of Health &; Human Services; HEALTH outcome assessment; MEDICAL protocols; DRUGS; CD4 lymphocyte count; SYMPTOMS; ADULTS
- Publication
Clinical Infectious Diseases, 2021, Vol 73, Issue 7, pe2334
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciaa1904